Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 111 - 119 of 119 results for "Pharmaceuticals"

Market wrap

... Wattyl, Novogen, Hills Industries, SkyCity Entertainment, Biota Holdings, Epitan, Adelaide Bank and Metabolic Pharmaceuticals all front shareholders. WELLINGTON - The sharemarket took the much anticipated interest rate rise in its stride, with the benchmark ...

Market wrap

AAP  |  TUESDAY, 23 AUG 2005
... billion hostile takeover offer for transport group Patrick and news of a merger between drug maker Sigma and Arrow Pharmaceuticals. Yesterday the S&P/ASX 200 index closed 37.7 points higher at 4499.3 and the all ordinaries gained 32.8 points to 4462.7. ...

Record IPO Activity: It's crazy out there says Deloitte

... performances of a number of explorers are attributed to the positive increase in IPOs for this sector. Activity in the pharmaceuticals and biotechnology sector increased from 5 IPOs in 2003 to 14 IPOs raising 175 million in 2004. Diversified financials ...

Emerging opportunities not just in China: Franklin Templeton

... five years ago, yet it is fast becoming a leading exporter while India is often seen as purely an IT economy, but pharmaceuticals and automotive are other sectors of strength. In Russia, the retail industry has enormous potential and opportunity as it ...

US and Australia sign free trade agreement

... and wood and paper products. Australian manufacturing exports to the United States will also grow, largely in pharmaceuticals, light commercial vehicles and motor vehicle parts, according to the statement. Many agricultural products are also covered ...

Midday market wrap: Shares, bonds both ease on stronger US data

... prospectus today for its $2 billion float which is likely to take place before the end of the year. Healthcare and pharmaceuticals conglomerate Mayne Group today said it was budgeting for higher earnings in 2003/04 from its remaining businesses, while ...

Healthcare expenditure at record highs: OECD

... - including Australia - is at a record high, with the bulk of that spending largely due to the rising cost of pharmaceuticals and the diffusion of modern medical technologies. The OECD's latest Health Data 2003 report on the matter shows that healthcare ...

ABS releases third survey on venture capital trends

... the average days spent on deals in 2001-02 was reflected in deals involving all activities except biotechnology, pharmaceuticals and health, which increased slightly over the previous year. Venture capital managers had typically between three and six ...

March quarter records highest price rises since 1995: ABS

... most to the overall increase this quarter were rises in the cost of automotive fuel (8.6%), vegetables (11.7%), pharmaceuticals (11.8%), secondary education fees (6.9%) and electricity (5.2%). Partially offsetting these increases were falls in the cost ...